[Late results of lung cancer therapy (according to material from the Kazakh Scientific Research Institute of Oncology and Radiology)].
The remote results in 295 patients subjected to radical surgical therapy are analysed, in 95 of these patients during two postoperative years 426 courses of chemotherapy were conducted. In squamous cell cancer of the lung 48 patients were administered methotrexate (90 mg per course), 18 patients with adenocarcinoma--5-fluoruracil, 29 patients with undifferentiated cancer-cyclophosphane (3 g of each substance). The comparison of 3 and 5-year results depending on the stage, extent of surgical intervention and histological form of the tumor, indicated a considerable prolongation of life terms in patients, subjected to the combined treatment, as compared with solely surgical one.
D000230:Adenocarcinoma / Q000628:therapy; D002277:Carcinoma / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D008727:Methotrexate / Q000627:therapeutic use*
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Otdalennye rezul'taty lecheniia raka legkogo (po materialam Kazakhskogo NII onkologii i radiologii)